Metoject subcutaneous inj pen launches in Japan rheumatic arthritis treatment
22 May 2024 //
BIOSPECTRUM ASIA
Medac GmbH Advances Pharmacovigilance Technology
13 Sep 2023 //
PR NEWSWIRE
Glycostem, medac enter multi-purpose agreement for oNKord
01 Aug 2022 //
PRNEWSWIRE
Byondis Partners with Medac to Commercialize Antibody-Drug Conjugate
03 May 2022 //
CONTRACTPHARMA
FDA slaps back small-cap`s bid to repurpose 50-year-old chemotherapy
04 Aug 2021 //
ENDPTS
Medexus and medac GmbH enter into Licensing Agreement for Treosulfan, in Canada
12 Jul 2021 //
GLOBENEWSWIRE
Vedanta Biosciences closes extended $45.5 million Series C funding
13 May 2019 //
BIOSPECTRUM ASIA
Medac Appoints Industry Veteran as Vice President of Sales in the U.S.
13 Dec 2016 //
PR NEWSWIRE
Medac`s Pemetrexed receive market authorisation in EU for Cancer
09 Dec 2015 //
EMA